Literature DB >> 33433123

Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.

Heidi M Crane1, Robin M Nance1, Bridget M Whitney1, Susan R Heckbert1, Matthew Budoff2, Kevin High3, Alan Landay4, Matthew Feinstein5, Richard D Moore6, William Christopher Mathews7, Katerina Christopoulos8, Michael S Saag9, Amanda Willig9, Joseph J Eron10, Mari M Kitahata1, Joseph A C Delaney1,11.   

Abstract

BACKGROUND: Type 1 myocardial infarctions (T1MIs) result from atherosclerotic plaque instability, rupture, and/or erosion. Type 2 MIs (T2MIs) are secondary to causes such as sepsis and cocaine-induced vasospasm resulting in an oxygen demand-supply mismatch and are associated with higher mortality than T1MIs. T2MIs account for a higher proportion of MIs among people living with HIV (PLWH) compared with the general population. We compared MI rates by type among aging PLWH. We hypothesized that increases in MI rates with older age would differ by MI types, and T2MIs would be more common than T1MIs in younger individuals.
METHODS: Potential MIs from 6 sites were centrally adjudicated using physician notes, electrocardiograms, procedure results, and laboratory results. Reviewers categorized MIs by type and identified causes of T2MIs. We calculated T1MI and T2MI incidence rates. Incidence rate ratios were calculated for T2MI vs. T1MI rates per decade of age.
RESULTS: We included 462 T1MIs (52%) and 413 T2MIs (48%). T1MI rates increased with older age, although T1MIs occurred in all age decades including young adults. T2MI rates were significantly higher than T1MI rates for PLWH younger than 40 years. T1MI rates were similar or higher than T2MI rates among those older than 40 years (significantly higher for those aged 50-59 and 60-69 years).
CONCLUSIONS: Rates of T2MIs were higher than T1MIs until age 40 years among PLWH, differing from the general population, but rates of both were high among older PLWH. Given prognostic differences between MI types, these results highlight the importance of differentiating MI types among PLWH.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33433123      PMCID: PMC8900222          DOI: 10.1097/QAI.0000000000002534

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  22 in total

1.  Universal definition of myocardial infarction: clinical insights.

Authors:  Luis Paiva; Rui Providência; Sérgio Barra; Paulo Dinis; Ana C Faustino; Lino Gonçalves
Journal:  Cardiology       Date:  2015-03-27       Impact factor: 1.869

Review 2.  Type 2 Myocardial Infarction: JACC Review Topic of the Week.

Authors:  Yader Sandoval; Allan S Jaffe
Journal:  J Am Coll Cardiol       Date:  2019-04-16       Impact factor: 24.094

3.  Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.

Authors:  H M Crane; S R Heckbert; D R Drozd; M J Budoff; J A C Delaney; C Rodriguez; P Paramsothy; W B Lober; G Burkholder; J H Willig; M J Mugavero; W C Mathews; P K Crane; R D Moore; S Napravnik; J J Eron; P Hunt; E Geng; P Hsue; G S Barnes; J McReynolds; I Peter; C Grunfeld; M S Saag; M M Kitahata
Journal:  Am J Epidemiol       Date:  2014-03-11       Impact factor: 4.897

4.  Type 2 myocardial infarction in clinical practice.

Authors:  Tomasz Baron; Kristina Hambraeus; Johan Sundström; David Erlinge; Tomas Jernberg; Bertil Lindahl
Journal:  Heart       Date:  2014-10-20       Impact factor: 5.994

5.  Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.

Authors:  Jorge Díaz-Garzón; Yader Sandoval; Stephen W Smith; Sara Love; Karen Schulz; Sarah E Thordsen; Benjamin K Johnson; Brian Driver; Katherine Jacoby; Michelle D Carlson; Kenneth W Dodd; Johanna Moore; Nathaniel L Scott; Charles A Bruen; Ryan Hatch; Fred S Apple
Journal:  Clin Chem       Date:  2016-11-03       Impact factor: 8.327

6.  Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.

Authors:  David A Morrow; Stephen D Wiviott; Harvey D White; Jose C Nicolau; Ezio Bramucci; Sabina A Murphy; Marc P Bonaca; Christian T Ruff; Benjamin M Scirica; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

7.  Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies.

Authors:  Sonu Gupta; Satyanarayana R Vaidya; Sameer Arora; Amol Bahekar; Santhosh R Devarapally
Journal:  Cardiovasc Diagn Ther       Date:  2017-08

8.  The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study.

Authors:  Tor Melberg; Robert Burman; Kenneth Dickstein
Journal:  Int J Cardiol       Date:  2008-11-22       Impact factor: 4.164

9.  Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).

Authors:  Matthew J Feinstein; Robin M Nance; J A Chris Delaney; Susan R Heckbert; Matthew J Budoff; Daniel R Drozd; Greer A Burkholder; James H Willig; Michael J Mugavero; William C Mathews; Richard D Moore; Joseph J Eron; Sonia Napravnik; Peter W Hunt; Elvin Geng; Priscilla Hsue; Inga Peter; William B Lober; Kristina Crothers; Carl Grunfeld; Michael S Saag; Mari M Kitahata; Donald M Lloyd-Jones; Heidi M Crane
Journal:  BMC Med       Date:  2019-07-31       Impact factor: 8.775

10.  Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting.

Authors:  Sameer Arora; Paula D Strassle; Arman Qamar; Evan N Wheeler; Alexandra L Levine; Jacob A Misenheimer; Matthew A Cavender; George A Stouffer; Prashant Kaul
Journal:  J Am Heart Assoc       Date:  2018-03-26       Impact factor: 5.501

View more
  1 in total

1.  HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort.

Authors:  Heidi M Crane; Lydia Drumright
Journal:  J Acquir Immune Defic Syndr       Date:  2022-02-01       Impact factor: 3.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.